In contrast, patients with T2D who have not undergone bariatric procedures fully responded to the DPP-4 inhibitor with improved glucose tolerance and insulin secretion, when DPP-4 inhibitor was combined with Ex-9 [156,157]. This evidence concerns the gene INS and type 2 diabetes mellitus.